Phio Pharmaceuticals Corp. (PHIO) › Operating Cash FlowPhio Pharmaceuticals Corp. (PHIO) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2012: -$5.06M2013: -$6.31M2017: -$9.51M2018: -$7.52M2019: -$8.64M2020: -$8.80M2021: -$11.86M2022: -$12.13M2023: -$10.75M2024: -$7.11M2025: -$7.98M-$7.98M2012Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$7.98M-12.2%2024-$7.11M+33.8%2023-$10.75M+11.4%2022-$12.13M-2.3%2021-$11.86M-34.7%2020-$8.80M-1.8%2019-$8.64M-15.0%2018-$7.52M+21.0%2017-$9.51M—2013-$6.31M-24.7%2012-$5.06M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share